Literature DB >> 14889758

The kidney of scleroderma.

H C MOORE, H L SHEEHAN.   

Abstract

Entities:  

Keywords:  KIDNEYS; SCLERODERMA/complications

Mesh：

Year:  1952        PMID： 14889758     DOI： 10.1016/s0140-6736(52)91798-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Viscero-cutaneous collagenosis; a study of the intermediate forms of dermatomyositis, scleroderma, and disseminated lupus erythematosus.

Authors:  W PAGEL; C S TREIP
Journal:  J Clin Pathol       Date:  1955-02       Impact factor: 3.411

2.  The heart in scleroderma.

Authors:  S ORAM; W STOKES
Journal:  Br Heart J       Date:  1961-05

3.  Clinical significance of the rheumatoid serum factor.

Authors:  J H KELLGREN; J BALL
Journal:  Br Med J       Date:  1959-02-28

4.  Peripheral neuropathy in the "collagen diseases": a case of scleroderma neuropathy.

Authors:  R F KIBLER; F C ROSE
Journal:  Br Med J       Date:  1960-06-11

5.  Some aspects of the pathology of collagen diseases.

Authors:  L SOKOLOFF
Journal:  Bull N Y Acad Med       Date:  1956-10

Review 6.  Scleroderma renal crisis: new insights and developments.

Authors:  Elisa Y Rhew; Walter G Barr
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

7.  Resolution of cutaneous manifestations of systemic sclerosis after haemodialysis.

Authors:  D J Barker; M J Farr
Journal:  Br Med J       Date:  1976-02-28

8.  The pathogenesis of the cotton wool spot in diabetic retinopathy.

Authors:  E C Madson; E M Chester
Journal:  Doc Ophthalmol       Date:  1974-11       Impact factor: 2.379

9.  Eosinophilic fasciitis. Case report and review of the literature.

Authors:  R M Bennett; A Herron; L Keogh
Journal:  Ann Rheum Dis       Date:  1977-08       Impact factor: 19.103

Review 10.  Scleroderma renal crisis: a rare but severe complication of systemic sclerosis.

Authors:  Luc Mouthon; Alice Bérezné; Guillaume Bussone; Laure-Hélène Noël; Peter M Villiger; Loïc Guillevin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.